National Advocacy Platform will Champion Patient Access and Health Innovation
Ottawa, September 16 – Innovative Medicines Canada (IMC) is proud to announce the official launch of Medicine Matters Canada, a new national public advocacy platform dedicated to improving patient access to innovative medicines and strengthening Canada’s life sciences sector.
“This is a major milestone in our mission to ensure faster access to new medicines, protect patient well-being, and drive economic growth through a thriving life sciences ecosystem. It’s built to inform, inspire, and empower Canadians from coast to coast to be in charge of their health,” said Dr. Bettina Hamelin, President and CEO, Innovative Medicines Canada.
A Platform with Purpose
Medicine Matters Canada will serve as a central hub to support and amplify IMC’s advocacy priorities, which at launch include:
- Improving access to new medicines
- Preserving and expanding coverage and treatment options
- Protecting medicines from tariffs
- Strengthening Canada’s economy through a thriving life sciences sector
The initiative features a fully bilingual website and a nationwide advertising campaign aimed at educating and mobilizing Canadians to act.
A Call to Action for All Canadians
Through storytelling, grassroots engagement, and interactive advocacy tools, Medicine Matters Canada empowers Canadians to voice their concerns and work towards better health policies. Visitors to the site can explore real-world impacts, watch explainer videos, and share their support across their own networks to amplify the campaign’s messages.
“This platform gives Canadians a voice in shaping a healthier, more innovative and more prosperous future,” added Dr. Hamelin.
About Innovative Medicines Canada
Innovative Medicines Canada is the national association representing Canada’s innovative pharmaceutical industry. The association advocates for policies that enable the discovery, development, and delivery of innovative medicines and vaccines to improve the lives of all Canadians and supports the members’ commitment to being a valued partner in the Canadian healthcare system. The association represents 47 member companies that invest $3.2 billion in R&D annually, fueling Canada’s knowledge-based economy, while contributing $18.4 billion per year to Canada’s knowledge-based economy. Guided by the Code of Ethical Practices, all members work with governments, private payers, healthcare professionals, and stakeholders in a highly ethical manner.
For further information: media@imc-mnc.ca
